PPHN is a serious condition where a newborn’s blood vessels in the lungs remain constricted after birth, hindering oxygen flow. This prevents the lungs from functioning properly, leading to low blood oxygen levels (hypoxemia) and high blood pressure in the pulmonary arteries.
Several factors contribute to PPHN. These include meconium aspiration syndrome (MAS), congenital diaphragmatic hernia (CDH), group B streptococcal infection, and other lung and heart conditions present at birth. In some cases, the exact cause remains unknown.
Diagnosis involves checking blood oxygen levels, performing a chest X-ray to assess lung condition, and potentially using echocardiography to visualize heart function. Early and accurate diagnosis is key for timely intervention.
Treatment focuses on improving blood oxygen levels and reducing pulmonary vascular resistance. This often includes supplemental oxygen, inhaled nitric oxide (iNO), and medications to improve blood flow to the lungs. In severe cases, extracorporeal membrane oxygenation (ECMO) may be necessary.
The prognosis depends on the severity of the condition and the presence of other health issues. Early intervention and aggressive treatment significantly improve outcomes. Long-term follow-up is recommended to monitor lung function and overall development.
Parents should discuss treatment options and prognosis with their healthcare providers. A multidisciplinary team, including neonatologists, respiratory therapists, and cardiologists, typically manages PPHN care.
